These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3069430)

  • 1. Analysis of methotrexate in cerebrospinal fluid by fluorescence polarization immunoassay.
    Glasco GB; Taylor EH; Chadduck WM; Pappas AA
    Drug Intell Clin Pharm; 1988 Nov; 22(11):912-3. PubMed ID: 3069430
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatography.
    Slørdal L; Prytz PS; Pettersen I; Aarbakke J
    Ther Drug Monit; 1986; 8(3):368-72. PubMed ID: 3529519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Abe T; Kobayashi H
    Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma.
    Morikawa N; Mori T; Kamenofuchi Y; Kawashima H; Takeyama M; Hori S
    Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of methotrexate transport from cerebrospinal fluid by probenecid.
    Spector R
    Cancer Treat Rep; 1976 Jul; 60(7):913-6. PubMed ID: 1009521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Methotrexate in cerebrospinal fluid.
    Zweig M
    N Engl J Med; 1976 Jan; 294(1):52. PubMed ID: 1244476
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of methotrexate on results by three methods for determining protein in cerebrospinal fluid.
    Zweig MH
    Clin Chem; 1977 Sep; 23(9):1773-4. PubMed ID: 890922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay of the human chorionic gonadotrophin using fluorescence polarization.
    Urios P; Cittanova N; Jayle MF
    FEBS Lett; 1978 Oct; 94(1):54-8. PubMed ID: 359357
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):774-7. PubMed ID: 10864035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of methotrexate with the determination of the protein content of cerebrospinal fluid.
    Verweij WM; Ossenkoppele GJ; Wijermans P
    Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():612. PubMed ID: 3767301
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
    Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
    Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluorescence polarization immunoassay, a new measuring technic in routine clinicochemical diagnosis of drug levels].
    Liappis N
    Klin Padiatr; 1985; 197(4):302-4. PubMed ID: 3900551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate: methotrexate and 7-hydroxymethotrexate diffusion in cerebrospinal fluid.
    Payet B; Tubiana N; Lejeune C; Guérin B; Cano JP; Carcassonne Y
    Int J Cancer; 1988 Jul; 42(1):135-6. PubMed ID: 3391703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determining the methotrexate concentration in serum with the fluorescence polarization immunoassay (FPIA)--a comparison with the enzyme immunoassay (EMIT)].
    Liappis N
    Klin Padiatr; 1986; 198(1):33-6. PubMed ID: 3515034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence immunoassay.
    Hicks JM
    Hum Pathol; 1984 Feb; 15(2):112-6. PubMed ID: 6365732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Methotrexate in cerebrospinal fluid.
    N Engl J Med; 1975 Nov; 293(22):1151-2. PubMed ID: 1242517
    [No Abstract]   [Full Text] [Related]  

  • 17. Modified fluorescence polarization immunoassay compared with radial partition immunoassay and a radioimmunoassay for digoxin.
    Cilissen J; Hooymans PM; Merkus FW
    Clin Chem; 1986 Nov; 32(11):2100. PubMed ID: 3536174
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):784-7. PubMed ID: 10864038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.
    Gilchrist NL; Caldwell J; Watson ID; Cunningham D; Forrest GJ; Soukop M; Stewart M; Fitch W
    Cancer Chemother Pharmacol; 1985; 15(3):290-4. PubMed ID: 4053271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.